Concepedia

Kelly Regal

KR

Statistics

Publications

15

Citations

591

H-Index

13

Active since

1998

Affiliations

Array BioPharma (United States)(Current)

Amgen (United States)

University of Washington

University of Michigan

Kelly Regal is an author at Array BioPharma (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1998–2022

15

Publications

15

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

Roland W. Bürli, Han Xu, Xiaoming Zou et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 125 citations · Full text

, , +6

Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation

Jean-Christophe Harmange, Matthew M. Weiss, Julie Germain et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

, , +17

Detection and Characterization of DNA Adducts of 3-Methylindole

Kelly Regal, George M. Laws, Yuan Cai et al. · Chemical Research in Toxicology · 2001 · 64 citations

Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species

Kevin W. Hunt, Adam W. Cook, Ryan J. Watts et al. · Journal of Medicinal Chemistry · 2013 · 58 citations · Full text

Mechanism-Based Inactivation of Cytochrome P450 2B1 by 7-Ethynylcoumarin:  Verification of Apo-P450 Adduction by Electrospray Ion Trap Mass Spectrometry

Kelly Regal, Michael Schrag, Ute M. Kent et al. · Chemical Research in Toxicology · 2000 · 43 citations

, , +20

1–5 of 15